NGVB Logo

NGVB Facilitated Publications

PUBLICATIONS THAT UTILIZED NGVB RESOURCES – PROVIDED BY NGVB USERS

 

2008

  1. Daud, A.I., DeConti, R. C., Andrews, S., Urbas, P., Ricker, I., Sondak, V. K., Munster, P.N., Sullivan, D. M., Ugen, K.E., Messina, J. L., Heller, R.. Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients with Metastatic Melanoma. Journal of Clin Oncol., 26:5896-903, 2008 PMC2645111.
  2. Glorioso J.C., Fink. D. J. Herpes Vector –mediated Gene Transfer in the treatment of Chronic Pain. Molecular Ther. 17:13-8. 2008 PMC2613169
  3. Hauswirth, W.W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. S. Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., Jacobson, S. G..  Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial. Hum Gene Therapy. 19:979-90. 2008. PMID 18774912. Free PMC article PMC2940541
  4. Peters, B., Discherl. S., Dantzer, J., Nowacki, N., Cross S., Cornetta, K., Dinauer, M.C., and Mooney SD. Automated analysis of viral integration sites in gene therapy research using the SeqMap web resource. Gene Ther.15:1294-8, 2008. PMC2766545
  5. Sheets, R. L, Stein, J., Bailer, R. T., Koup, R. A., Nason, M., He, B., Koo, E., Trotter, H.,  Duffy, C., Manetz, T. S., Gomez, G. Biodistribution and Toxicological Safety of Adenovirus Type 5 and Type 35 Vectored Vaccines Against Human Immunodeficiency Virus-1 (HIV-1), Ebola, or Marburg Are Similar Despite Differing Adenovirus Serotype Vector, Manufacturer’s Construct, or Gene Inserts. Journal of Immunotoxicol. 5:315-35.2008 PMC2777703

 

2009

  1. Brantly, M.L., Chulay, J. D., Wang, W., Mueller, C., Humphries, M., Spencer, L. T., Rouhania, F., Conlon, T. J., Calcedo, R., Betts, B., Spencer, S., Byrne, B. J., Wilson, J. M., Flotte, T. R. Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy. PNAS USA.  106:16363–8, 2009.  PMC2752529.
  2. Cideciyan, A. V., Hauswirth, W. W., Aleman, T. S., Kaushal, S., Schwartz, S. B., Boye, S. L., Windsor, E. A. M., Conlon, T. J., Sumaroka, A., Pang, J-J., Roman, A. J., Byrne, B. J., Jacobson, S. G. Human RPE65 Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 Year. Human Gene Thera. 20:999-1004, 2009. PMC2829287
  3. Cornetta, K.,Matheson, L. The National Gene Vector Biorepository Pharm/Tox Database. Mol. Ther. 17(4):582-4. 2009. PMC2835100.
  4. Hammond, H. K. Tang, T. Gene therapy for myocardial infarction–associated congestive heart failure: how far have we got? Dialogues in Cardiovascular Medicine 14:27-51. 2009. PMC3119547.
  5. Hao, S., Wolfe, D., Glorioso, J.C., Mata, M., Fink, D. J. Effects of transgene-mediated endomorphin-2 in inflammatory pain. European Journal of Pain. 13: 380-6. 2009. PMC2656597
  6. Hollyman DR,Stefanski J, Przybylowski M, Bartido S, Borquez-Ojeda 0, Taylor C, Yeh R, Capacio V, Olszewska M,  Hosey J,Sadelain M, Brentjens RJ, Rivière I. Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy. J Immunotherapy 32:169–180. 2009. PMC2683970
  7. Margolis, D. J., Lee M. Morris, L. M., Papadopoulos, M., Weinberg, L., Filip, J. C.,  Lang, S. A., Vaikunth S., Crombleholme, T. M. Phase I Study of H5.020CMV.PDGF-B to Treat Venous Leg Ulcer Disease. Mol. Ther. 17:1822-9, 2009. PMC2835007
  8. Mendell, J. R., Rodino-Klapac, L. R., Rosales-Quintero, X., Kota, J., Coley, B. D., Galloway, G., Craenen, J. M., Lewis, S., Malik, V., Shilling, C., Byrne,B. J., Conlon, T., Campbell, K. J., Bremer, W. G.,  Viollet, L., Walker, C. M. , Sahenk, Z., and Clark, K. R. . Limb-Girdle Muscular Dystrophy Type 2D Gene Therapy Restores alpha-Sarcoglycan and Associated Proteins. Ann Neurol. 66:290-7. 2009 PMID 19798725, PMCID: PMC6014624
  9. Wolfe, D.,Mata M., Fink, D. J.. A Human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther. 16: 455-60, 2009.  PMC2683467.

 

2010

  1. Flotte, T. R., Fischer, A. C., Goetzmann, J., Mueller, C., Cebotaru, L., Yan, Z., Wang, W., Wilson, J. W., Guggino, W. B., Engelhardt, J. F.  Dual Reporter Comparative Indexing of rAAV Pseudotyped Vectors in Chimpanzee Airway. Mol.Ther.18:594-600. 2010. PMC2839428.
  2. Gerrits, A., Dykstra, B., Kalmykowa, O. J., Klauke, K., Verovskaya, E., Broekhuis, M. J. C., de Haan, G., Bystrykh, L. V.  Cellular barcoding tool for clonal analysis in the hematopoietic system.  Blood 115:2610-8, 2010. PMID20093403 epub 2010 Jan 21
  3. Kochenderfer, J.N., Wilson, W.H., Janik, J.E., Dudley, M.E. Stetler-Stevenson, M., Feldman, S.A., Maric, I., Raffeld, M., Nathan, D. N., Lanier, B. J., Morgan, R..A., Rosenberg, S. A.  Eradication of B-lineage cells and regression of  lymphoma in a patient treated with autologous T cells genetically-engineered  to recognize CD19.  Blood. 116:4099-4102, 2010.  PMC2993617
  4. Siprashvili Z,Nguyen NTA, Bezchinsky MY, Marinkovich VP, Lane A, Khavari PA. Long-Term Type VII Collagen Restoration to Human Epidermolysis Bullosa Skin Tissue. Hum Gene Ther.  Oct; 21(10):1299-310. 2010. PMC 2957245

 

2011

  1. Brentjens RJ, Rivière I, Park JH, Davila ML, Wang X, Stefanski J, Taylor C, Yeh R, Bartido S, Borquez-Ojeda O, Olszewska M, Bernal Y, Pegram H, Przybylowski M, Hollyman D, Usachenko Y, Pirraglia D, Hosey J, Santos E, Halton E, Maslak P, Scheinberg D, Jurcic J, Heaney M, Heller G, Frattini M, Sadelain M. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood 118:4817-28.2011.PMC 3208293
  2. Brown, A., Islam, T., Adams, R., Nerle, S.,Kamara, M., Eger, C. Marder, K. Cohen, B., Schifitto, G.,  & Justin C. McArthur, J. C., Sacktor, N., Pardo, C. A. Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals. Journal of Neurovirology 17:382-392, 2011.  PMC3331788
  3. Cornetta, K., Yao J., Jasti A., Koop, S., Douglas, M., Hsu, D., Couture, L. A., Hawkins, T., Duffy, L. Replication Competent Lentivirus Analysis of Clinical Grade Vector Products. Mol Ther.19:557-66, 2011. PMC3048188.
  4. Di Stasi, A., Tey, S. K, Dotti, G., Fujita, Y., Kennedy-Nasser, A., Martinez, C., Straathof, K., Liu, E., Durett, A. G., Grilley, B., Liu, H., Cruz, C. R., Savoldo, B., Gee, A. P., Schindler, J., Krance, R. A., Heslop, H. E., Spencer, D. M., Rooney, C. M., Brenner, M. K.. Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med. 365:1673-83, 2011. PMC3236370.
  5. Hawkins, T. B., Danzer, J., Peters, B., Dinauer, M. C., Mockaitis, K., Mooney, S., Cornetta, K. Identifying viral integration sites using SeqMap 2.0. Bioinformatics. 27:720-2, 2011. PMC3042184
  6. Gorell, E., Tichey A., and Lane, A.,Successful investigational new drug preparation without reinventing the wheel. J Invest Dermatol. 131 (5): 966-8 2011. PMID 21494234 doi: 10.1038/jid.2011.38.
  7. Louis, C. U., Savoldo, B., Dotti, G., Pule, M., Yvon, E., Myers, G. D., Rossig, C., Russell, H. V. Diouf, O., Liu, E., Liu, H., Wu, M. F., Gee, A. P., Mei, Z., Rooney, C. M., Heslop, H. E., Brenner, M. K. Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood. 118:6050-6, 2011.  PMC3234664.
  8. Ma, C., Fan, R., Ahmad, H., Shi, Q., Comin-Anduix, B., Chodon, T., Koya, R. C., Liu, C-C., Kwong, G. A., Radu, C. G., Ribas, A., Heath, J. R.  A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells. Nature Medicine 17:738-43, 2011.    PMC3681612
  9. Savoldo, B., Ramos, C. A., Liu, E., Mims, M. P., Keating, M. J., Carrum, G., Kamble, R. T., Bollard, C. M., Gee, A. P., Mei, Z., Liu, H., Grilley, B., Rooney, C. M., Heslop, H. E., Brenner, M. K., Dotti, G. CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. J Clin Invest. 121:1822-6, 2011. PMC3083795.

 

2012

  1. Adair, J. E., Beard, B. C., Trobridge, G. T., Neff, T.,Rockhill, J. K., Silbergeld , D. L., Mrugala, M. M., Hans-Peter Kiem, H-P. Extended Survival of Glioblastoma Patients After Chemoprotective HSC Gene Therapy. Science Transl.  4:133ra57, 2012.  PMC3650895
  2. Al-Mehdi, A. B., Pastukh, V. M., Swiger, B. M., Reed, D. J., Patel, M. R., Bardwell, G. C., Pastukh, V. V., Alexeyev, M. F., Gillespie, M. N. Perinuclear mitochondrial clustering creates an oxidant-rich nuclear domain required for hypoxia-induced transcription.Sci Signal. 5:ra47. 2012 PMC3565837
  3. Candotti, F., Shaw, K. L., Muul, L., Carbonaro, D., Sokolic, R., Choi, C., Schurman, S. H., Garabedian, E., Kesserwan, C., Jagadeesh, G. J., Fu, P.Y., Gschweng, E., Cooper, A., Tisdale, J. F., Weinberg, K. I., Crooks, G. M., Kapoor, N., Shah, A., Abdel-Azim, H., Yu, X. J., Smogorzewska, M., Wayne, A. S., Rosenblatt, H. M., Davis, C. M., Hanson, C., Rishi, R. G., Wang, X., Gjertson, D., Yang, O. O., Balamurugan, A., Bauer, G., Ireland, J. A., Engel, B. C., Podsakoff, G. M,. Hershfield MS, Blaese RM, Parkman R, Kohn DB. Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans. Blood. 120:3635-46. 2012   PMC3488882
  4. Cioffi, D. L., Wu, S., Chen, H., Alexeyev, M., St Croix, C. M., Pitt, B. R., Uhlig, S., Stevens, T. Orai1 determines calcium selectivity of an endogenous TRPC heterotetramer channel. Circ Res. 110:1435-44. 2012.  PMC3388001
  5. Gerrits, A., Walasek, M. A., Olthof, S., Weersing, E., Ritsema, M., Zwart, E., van Os, R., Bystrykh, L. V., de Haan, G. Genetic screen identifies microRNA cluster 99b/let-7e/125a as a regulator of primitive hematopoietic cells. Blood 119:377-87 2012. PMID: 22123844.
  6. Green, M.R., Lockey, T., Mehta, P. K., Kim, Y. S., Eldridge, P. A. W., Gray, J. T., Sorrentino, B. P. Transduction of human CD34+ Repopulating Cells with a Self-inactivating Lentiviral Vector for SCID-X1 Produced at Clinical Scale by a Stable Cell Line. Human Gene Therapy Methods. 23:297-308, 2012.  PMC3732136
  7. Heck JN, Ponik SM, Garcia-Mendoza MG, Pehlke CA, Inman DR, Eliceiri KW, Keely PJ. Microtubules regulate GEF-H1 in response to extracellular matrix stiffness. Mol Biol Cell. Jul;23 (13):2583-92 2012. PMC3386221
  8. Leath, A., and Cornetta, K. Developing novel lentiviral vectors into clinical products. Methods in Enzymology, 507:89-108, 2012. PMID: 22365770  DOI 10.1016/B978-0-12-386509-0.00005-3
  9. Kochenderfer, J.N., Dudley, M.E. , Feldman, S.A. , Wilson, W.H., Spaner, D.E., Maric,  I. Stetler-Stevenson, M., Phan, G.Q. , Hughes, M.S., Sherry, R.M., Yang, J.C. , Kammula, U.S., Devillier, L., Carpenter, R., Nathan, D. N., Morgan, R.A.,  Laurencot, C., Rosenberg, S.A..  B-cell Depletion and Remissions of Malignancy Along With Cytokine- associated Toxicity in a Clinical Trial of T Cells Genetically-modified to Express an Anti-CD19 Chimeric Antigen Receptor.  Plenary Paper.  Blood. 119: 2709-2720, 2012.    PMC3327450
  10. Ochoa, C. D., Alexeyev, M., Pastukh, V., Balczon, R., Stevens, T. Pseudomonas aeruginosa exotoxin Y is a promiscuous cyclase that increases endothelial tau phosphorylation and permeability. J Biol Chem. 287:25407-18. 2012.    PMC3408204
  11. Snook., A. E., Magee, M., Marszalowicz, G. P., Schulz, S., Waldman, S. A.  "Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C." Cancer Immunol Immunother. 61:713-23. 2012. doi: 10.1007/s00262-011-1133-0. Epub 2011 Nov 6

 

2013

  1. Aachoui, Y., Leaf, I. A., Hagar, J. A., Fontana, M. F., Dampos, C. G., Zak, D. E., Tan, M. H., Cotter, P. A. , Vance, R. E. , Aderem, A., Miao, E. A. Caspase-11 Protects Against Bacteria That Escape the Vacuole.  Science. 339:975-8. 2013 PMC 3697099
  2. Adler JJ, Heller BL, Bringman LR, Ranahan WP, Cocklin RR, Goebl MG, Oh M, Lim HS, Ingham RJ, Wells CD. Amot130 adapts atrophin-1 interacting protein 4 to inhibit yes-associated protein signaling and cell growth. J Biol Chem. May 24;288(21):15181-93.2013. PMC3663538
  3. Adler JJ, Johnson DE, Heller BL, Bringman LR, Ranahan WP, Conwell MD, Sun Y, Hudmon A, Wells CD. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases. Proc Natl Acad Sci U S A. Oct 22 110:(43):17368-73.2013. PMC3808603
  4. Aloia, A., Duffy, L., Pak, V., Lee, K., Sanchez-Martinez, S., Derse, D., Heidecker, G., Cornetta, K., and Rein, A. A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay. Gene Therapy 20:169-176, 2013. PMC 3374051
  5. Alzoubi A, Almalouf P,Toba M, O’Neill K, Qian X, et al. TRPC4 Inactivation confers a survival benefit in severe pulmonary arterial hypertension. Am J Pathol 183 (6):1779-1788 2013. PMID: 24113457 DOI: DOI: 10.1016/j.ajpath.2013.08.016 PMCID: PMC 5745549
  6. Babu R, and Brown A. A consensus surface activation mrker signature is partially dependent on human immunodeficiency virus type 1 Nef expression within productively infected macrophages. Retrovirology Dec16; 10:155. 2013. PMC3883119
  7. Balczon R, Prasain N, Ochoa C, Praer J, Zhu B, et al. Pseudomonas aeruginosa exotoxin Y-mediated tau hyperphosphorylatin impairs microtubule assembly in pulmonary microvascular endothelial cells. PLoS One Sept 4; 8(9):e74343, 2013. PMC3762819
  8. Boeke, A., Dumas, P., Reeves, L., McClurg, K., Bischof, D., Sego, L., Auberry, A., Tatikonda, M., Cornetta, K.  Vector Production in An Academic Environment: A Tool to Assess Production Costs. Human Gene Therapy Methods. 24: 49-57, 2013. PMC4015083
  9. Brentjens R.J,Davila M.L, Riviere  I, Park J, Wang X, L. G. Cowell L.G, Bartido S, Stefanski JTaylor C, Olszewska M, Borquez-Ojeda O, Qu J,Wasielewska T, He Q, Bernal Y, Rijo I.V. Hedvat C,Kobos R, Curran K, Steinherz P, Jurcic J,Rosenblat T, Maslak P,  Frattini M, Sadelain M. CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia. Sci. Transl. Med. 5, 177ra38. 2013.PMC3742551
  10. Cornetta, K., Tessanne, K., Long, C., Yao, J., Satterfield, C., Westhusin, M. Transgenic sheep generated by lentiviral vectors: Safety and integration analysis of surrogates and their offspring. Transgenic Research 22:737-45, 2013. PMC3606283
  11. Grupp, S A, Kalos, M., Barrett, D., Aplenc, A., Porter, D. L., Rheingold, S. R.., Teachey,D. T. ., Chew, A., Hauck, B., Wright, J. F.., Milone, M.C., Levine, B. L., June, C. Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia. N.ENGL J Med. 18;368(16):1509-18, 2013. PMC4058440
  12. Katwal, A. B.,, Konkalmatt, P. R., Piras, B.A., Hazarika, S., Li, S. S., Lye, R. J., Sanders, J. M., Ferrante, E. A., Yan, Z., Annex, B. H., French, B. A. Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery. Gene Therapy 20:930-8, 2013. PMC 3758463.
  13. Kochenderfer, J.N., Dudley,M.E., Carpenter, R.O.,  Kassim, S.H., Rose, J.J., Telford, W.G., Hakim, F.T.,  Halverson, D.C., Fowler, D.H.,  Hardy, N.M.,  Mato, A.R.,  Hickstein, D.D., Gea-Banacloche, J.C.,  Pavletic, S.Z.,  Sportes, C.,  Maric, I.,  Feldman, S.A., Hansen, B.G., Wilder, J.S.,  Blacklock-Schuver, B.,  Jena, B.,  Bishop, M.R., Gress* R.E.,* Rosenberg*, Steven A.,.(co-senior authors).   Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.  Blood:  2013 122:  4129-4139. PMID: 24055823. PMC 3862276
  14. Lin, J.Y. Production and validation of recombinant adeno-associated virus for channel rhodopsin expression in neurons. Methods in Molecular Biology  Ion channels: methods and protocols. 998:401-15, 2013. PMID: 23529447 doi: 10.1007/978-1-62703-351-0_31.
  15. Lin J.Y., Knutsen P.M., Muller A., Kleinfeld D. and Tsien R.Y.  ReaChR: A red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nature Neuroscience. 16:1499-508, 2013. PMC3793847
  16. Lin J.Y., Sann S.B., Zhou K., Nabavi S., Proulx C., Malinow R., Jin Y. and Tsien R.Y.. Optogenetic inhibition of synaptic release with chromophore-assisted light inactivation (CALI). Neuron.  79:241-53, 2013. PMC3804158
  17. Nguyen, T., Rich, A., Dahl, R. MiR-24 Promotes the Survival of Hematopoietic Cells. PLoS One. 8:e55406. 2013. PMC3559586
  18. O’Reilly, Marina,  Kohn, Donald B., Bartlett,Jeffrey, Benson, Janet, Brooks, Philip J., Byrne, Barry J, Camozzi, Carlos, Cornetta, Kenneth,  Crystal, Ronald G., Fong, Yuman, Gargiulo, Linda, Gopal-Srivastava, Rashmi, High, Katherine A.,Jacobson, Samuel G., Jambou, Robert C., Montgomery, Maureen, Rosenthal, Eugene,Samulski, R. Jude, Skarlatos, Sorrentino, Wilson, James M., Xie, Yun, and Corrigan-Curay, Jacqueline. Gene Therapy for Rare Diseases: Summary of a National Institutes of Health Workshop, September 13, 2012. Human Gene Therapy 24:355-362 (April 2013) doi: 10.1089/hum.2013.064  PMCID: PMC3631014
  19. Parra-Bonilla G, Alvarez DF, Alexeyev M, Vasauskas A, Stevens T. Lactate dehydrogenase a expression is necessary to sustain rapid angiogenesis of pulmonary microvascular endothelium. PLoS One Sep 26;8(9):e75984 2013. PMC3784391
  20. Ponik SM, Trier SM, Wozniak MA, Eliceiri KAW, Keely PJ. RhoA is down-regulated at cell-cell contacts via p190RhoGAP-B in response to tensional homeostasis. Mol Biol Cell. Jun; 24(11):1688-99, 2013. PMC3667722
  21. Romero Z, Urbinati F, Geiger S, Cooper A, Wherley J, Kaufman ML, Hollis R, Senadheera S,  Ruiz de Assin R, Sahagian A, Wang X, Gjertson D, DeOliveira S, Kempert P, Shupien S, Abdel-Azim H, Walters M, Meiselman HJ, Marder V, Coates TD, and Kohn DB. Beta globin Gene transfer to human bone marrow for sickle cell disease. J Clin Invest, 123:3317–3330,Jul 1 2013. PMID: 23863630 PMCID: PMC4011030
  22. Shokolenko IN, Fayzulin RZ, Katyal S, McKinnon PJ, Wilson GL, et al. Mitochondrial DNA ligase is dispensable for the viability of cultured cells but essential for mtDNA maintenance. J. Biol Chem 288 (37):26594-26605 2013. PMC3772206
  23. Shokolenko IN, Wilson GL, Alexeyev MF. Persistent damage induces mitochondrial mitochondrial DNA degradation. DNA Repair (Amst) 12:488-499. 2013. PMC3683391
  24. Struckhoff, A.P., Rana, M.K., Kher, S. S., Burow, M. E., Hagan, J. L., Del Valle, L., Worthylake, R. A. PDZ-RhoGEF (PRG) is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA.  J. Cell Sci. 126:4514-26, 2013 PMC3784824
  25. Watson, R. S., Broome, T. A., Rice, B. L., Kay, J. D.,, Smith, A. D., Gouze, E., Gouze, J-N, Levings, P. P., Dacanay, A., Hauswirth, W.W., Nickerson, D. M., Dark, M., Colahan, P. T., Ghivizzani, S.C.  scAAV-mediated gene transfer of interleukin-1 receptor antagonist to synovium and articular cartilage in large mammalian joints. Gene Ther. 20:670-7. 2013.  PMC3577988
  26. Wood, T. R., Chow, R. Y., Hanes C. M., Zhang, X., Kashiwagi, K., Shirai, Y., Trebak, M., Loegering, D. J., Saito, N., Lennartz, M. R.. PKC-{varepsilon} pseudosubstrate and catalytic activity are necessary for membrane delivery during IgG-mediated phagocytosis. J Leukoc Biol. 94:109-22, 2013. PMC3685018

 

2014

 

  1. Boulad F, Wang X, Qu J,Taylor C, Ferro L, Karponi G, Bartido S, Giardina P,Heller G, Prockop S.E, Maggio A, Sadelain M and Rivière I.  Safe mobilization of CD34+ cells in adults with beta-thalassemia and validation of effective globin gene transfer for clinical investigationBlood  Mar 6;123(10): 1483-6 2014. PMID: 24429337. PMC3945860.
  2. Chodon T, Begona C,Bartosz C, Koya R, Zhongqi W, Martin A, Ng C,Avramis E, Seja E, Villanueva A, McCannel T, Ishiyama A, Czernin, J, Radu G, Wang X, Gjertson D, Cochran A, Cornetta K, Wong D, Kaplan-Lefko, P, Hamid O, Samlowski W, Cohen P, Daniels G, Mukherji B, Yang L, Zaqck J, Kohn D, Heath J, Glaspy J, Witte O, Baltimore D, Economou J, and Ribas A. Adoptive transfer of MART-1 T cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma. Clin Cancer Res. doi:10.1158/1078-0432.CCR-13-3017 published online Mar 2014. PMID: 24634374. PMC 4070853
  3. Chodon T, Comin-Anduix B, Chmielowski B, Koya K, Wu Z, Allen-Auerbach M, Ng C, Avramis E, Seja E, Villanueva A, McCannel T, Ishiyama A, Czernin J, Radu C, Wang X, Gjertson D, Cochran A, Cornetta K, Wong D, Kaplan-Lefko P, Hamid O, Samlowski W, Cohen P, Daniels G, Mukherji B, Yang L, Zack J, Kohn D, Heath J, Glaspy J, Witte O, Baltimore D, Economou J and Ribas A.  2014.  Adoptive transfer of MART-1 T cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma.  Clin Cancer Res.  20:2457-65. PMCID: PMC4070853
  4. Carbonaro DA, Zhang L, Jin X, Montiel-Equihua C, Geiger S, Carmo M, Cooper A, Fairbanks L, Kaufman ML, Sebire NJ, Hollis RP, Blundell MP, Senadheera S, Fu PY, Sahaghian A, Chan RY, Wang X, Cornetta K, Thrasher AJ, Kohn DB, Gaspar HB. Pre-clinical demonstration of lentiviral vector mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency. Mol Ther.Mar 22(3):607-22.2014.PMID: 24256635, PMC:3944341
  5. Davila M.L, Riviere I, Wang X , Bartido S, Park J,  Curran K, Chung S.S, Stefanski J, Borquez-Ojeda O, Olszewska M, Qu J Wasielewska T, He Q, Fink M, Shinglot H., Youssif M, Satter M, Wang Y, Hosey J, Quintanilla H, Halton E, Bernal Y, Bouhassira D.C.G, Arcila M.E, Gonen M, Roboz G.J Maslak P, Douer D, Frattini M.G., Giralt S, Sadelain M, Brentjens R. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia. Sci. Transl. Med. 6, 224ra25. 2014. Doi:10.1126/scitranslmed.3008226. PMID 24553386. PMC 4684949
  6. Eissenberg, LG, Rettig, M, Dehdashti, F, Piwnica-Worms, D, and DiPersio, JF, (2014). Suicide genes:monitoring cells in patients with a safety switch. Front Pharmacol 6, 5:241.PMID: 25414668. PMC 4222135
  7. Gao, H., Hawkins, T., Jasti, A., Chen, Y.H., Mockaitis, K., Dinauer, M., Cornetta, K. Development and Evaluation of Quality Metrics for Bioinformatics Analysis of Viral Insertion Site Data Generated Using High Throughput Sequencing. Biomedicines 2014, 2(2), 195-210; doi:10.3390/biomedicines2020195 PMC5423470
  8. Hacein-Bey-Abina, S., Pai, S.-Y. Gaspar, H.B., Armant, M. Berry, C.C., Blanche, Bleesing, J.,Blondeau, H. de Boer, K.F. Buckland, L. Caccavelli,. Cros, G.m, De Oliveira, S., Fernández, K.S., Guo, D.,Harris, C.E.,Hopkins, G, Lehmann,L.E., A. Lim, W.B. London, J.C.M. van der Loo, N. Malani, F. Male, Malik, P., Marinovic, M.A, McNicol, A.-M.,Moshous,D.  Neven, B. Oleastro, M., Picard,C., Ritz, J.,C. Rivat, Schambach,A., Shaw,K.L., Sherman, E.A.,Silberstein, L.E., Six, E., Touzot, F.,  Tsytsykova, A.,  Xu-Bayford, J., Baum, C., Bushman, F.D., Fischer, A., Kohn, D.B., Filipovich, A.H., Notarangelo, L.D., Cavazzana, M., Williams, D.A., and Thrasher, A.J. A Modified γ-Retrovirus Vector for X-LinkedSevere Combined Immunodeficiency. N. ENGL J MED 2014;371:1407-17..Oct 9 2014. PMID: 25295500. PMC 4274995
  9. Kochenderer, J.N., Dudley, M.E.,Kassim, S.H., Somerville, R.P.T., Carpenter, R.O., Stetler-Stevenson, M., Yang, J.C.,Phan, G.Q., Hughes, M.S., Sherry, R.M., Raffeld, M., Feldman, S., Lu, L., Li, Y.F., Ngo, L.T., Goy, A., Feldman, T., Spaner, D.E., Wang, M.L., Chen, C.C., Kranick, S.M., Nath, A., Nahtan, D.N., Morton, K.E., Toomey, M.A., Rosenberg, S.A., Chemotherapy-refractory Diffuse Large B-cell Lymphoma and Indolent B-cell Malignancies Can be Effectively Treated with Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor. Rapid Communication Article. Journal of Clinical Oncology. 2014 Aug 25. PMID: 25154820. PMC4322257
  10. Shokolenko IN, Wilson GL, Alexeyev MF. The “Fast” and “slow” Modes of Mitochondrial DNA  Degradation: Mitochondrial DNA. 2014 Apr 14 PMID: 24724936. PMC4333107
  11. Xu N, Cioffi DL, Alexeyev M, Rich TC, Stevens T. Sodium Entry Through Endothelial Store Operated Calcium Entry Channels: Regulation by Orai1. Am J Physiol Cell Physiol. 2014 Nov 26: ajpcell.00063.2014. doi: 10.1152/ajpcell.00063.2014. PMID 25428882. PMC 4329424

 

2015

  1. Ahmed N, Brawley VS, Hegde M, Robertson C, Ghazi A, Gerken C, et al. Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma. J Clin Oncol. 2015; 33(15):1688-96. doi: JCO.2014.58.0225 [pii];10.1200/JCO.2014.58.0225 [doi]. PMC4429176
  2. Chang E, Liu H, West JA, Zhou X, Dakhova O, Wheeler DA, et al. Clonal Dynamics in vivo of Virus Integration Sites of T cells expressing a safety switch. Mol Ther. 2015. doi: 10.1038/mt.2015.217. PubMed PMID: 26639404. PMC4886929
  3. Eissenberg,  L.G., Rettig, M. P., Ritchey, J. K., Prior, J., Schwarz, S., Frye, J. White, B. S., Fulton, R., Ghobadi, A., Couriel, D., Seegulam, M. E., Piwnica-Worms, D., Dehdashti, F., Cornetta, K. DiPersio J. F. Infusion and [18F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T cells in Patients who Relapse after Allogeneic Stem Cell Transplant: Safety and Feasibility . Molecular Therapy; advance online publication 12 May 2015; doi: 10.1038/mt.2015.48. 2015 Jun; 23(6):1110-22 PMID 25807290, PMC4817759
  4. Fayzulin, R.Z., Perez, M., Kozhukhar, N., Spadafora,D., Wilson, G.L., and Alexeyev, M.F. (2015) A method for mutagenesis of mouse mtDNA and a resource of mouse mtDNA mutations for modeling human pathological conditions. Nucleic Acids Res. 43,(9) e62 Mar 27. PMID 25820427. PMCID: PMC4482060
  5. Jian, M. Y., Liu, Y., Li, Q., Wolkowicz, P., Alexeyev, M., Zmijewski, J.W., and Creighton, J.R. (2015) N-cadherin Coordinates AMP Kinase Mediated Lung Vascular Repair. AM.J. Physiol. Lung Cell Mol. Physiol., ajplung 00227 02015. PMID 26064452, PMC4698433
  6. Kozhukhar, N., Spadafora, D., Fayzulin, R., Shokolenkom, I.N., and Alexeyev, M. (2015) The efficiency of the translesion systheseis across abasic sites by mitochondrial DNA polymerase is low in mitochondria of 3T3 cells.  Mitochondrial DNA, Oct 16: 1-7. PMID 26470640, PMC4834068
  7. Lin Z, Zhou P, von Gise A, Gu F, Ma Q, Chen J, Guo H, van Gorp PR, Wang DZ, Pu WT. Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. Circ Res. 2015 Jan 2;116(1):35-45. doi:10.1161/CIRCRESAHA. 115.304457. Epub 2014 Sep 23. PMID:25249570, PMC4282610
  8. Nguyen, J.M., Qualmann, K.J., Okashah, R., Reilly, A., Alexeyev, M.F., and Campbell, D.J. (2015) 5p deletion: Current knowledge and future directions. Am. J. Med. Genet. C Semin. Med. Genet. 169, 224-238.PMID: 26235846, PMC4736720
  9. Prendiville TW, Guo H, Lin Z, Zhou P, Stevens SM, He A, VanDusen N, Chen J, Zhong L, Wang DZ, Gao G, Pu WT. Novel Roles of GATA4/6 in the Postnatal Heart Identified through Temporally Controlled, Cardiomyocyte-Specific Gene Inactivation by Adeno-Associated Virus Delivery of Cre Recombinase.  PLoS One. 2015 May 29;10(5):e0128105.doi:10:137/journal pone. 0128105. eCollection 2015. PMID: 26023924, PMC 4449121
  10. Shokolenko, I.N., and Alexeyev, M.F. (2015) Mitochondrial DNA: A disposable genome. Biochem Biophys. Acta 1852, 1805-1809. PMID 26071375, PMC4523420
  11. Xu, N., Cioffi, D.L., Alexeyev, M., Rich, T.C., and Stevens, T. (2015) Sodium entry through endothelial store-operated calcium entry channels: regulation by Orai1. AM.J. Physiol. Cell Physiol. 308, C277-288. PMID: 25428ro, PMC4329424
  12. Zhou X, Dotti G, Krance RA, Martinez CA, Naik S, Kamble RT, et al. Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation. Blood. 2015;125(26):4103-13. doi: 10.1182/blood-2015-02-628354. PubMed PMID: 25977584; PubMed Central PMCID: PMC4481597.
  13. Zhou X, Naik S, Dakhova O, Dotti G, Heslop HE, Brenner MK. Serial activation of the inducible caspase 9 safety switch after human stem cell transplantation. Mol Ther. 2015. doi: 10.1038/mt.2015.234. PubMed PMID: 26708005. PMC4886936

 

2016

  1. Brudno, J.N., Somerville, R.P.T., Shi, V., Rose, J.J., Halverson, D.C., Fowler, D.H., Gea-Banacloche, J.C., Pavletic, S.Z., Hickstein, D.D., Lu, T.L., Feldman, S.A., Iwamoto, A.T., Kurlander, R., Maric, I., Goy, A., Hansen, B.G., Wilder, J.S., Blacklock-Schuver, B., Hakim, F.T., Rosenberg, S.A., Gress, R.E. and Kochenderfer, J.N., Allogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell transplantation without causing graft-versus-host disease Journal of Clinical Oncology 34: 1112-1121, 2016. PMID: 26811520, PMCID: PMC4872017
  2. Chtarto, A,  Humbert-Claude, M. and Bockstael1,O, Das, A. T, Boutry, S., Breger, L. S., Klaver, B., Melas, C., Barroso-Chinea, P,Gonzalez-Hernandez, T.,Muller, R.N.,  DeWitte, O., Levivier, M., Lundberg, C., Berkhout, B., and Tenenbaum, L., A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses. Mol Ther. (2016), 5,16027, doi 10.1038/mtm.2016.27. PMID: 27069954, PMCID: PMC4813607
  3. Gardner, R., Wu D., Cherian, S., Fang, M., Hanafi, L., Finney, O., Smithers, H., Jensen, M.C., Riddell, S.R., Maloney, D.G., and #Turtle, C.J. 2016. Acquisition of a CD19 negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T cell therapy. Blood. 127(20):2406-10. PMID: 26907630 PMCID: PMC4874221
  4. Ramos CA, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, Liu E, Carrum G, Kamble RT, Gee AP, Mei Z, Wu MF, Liu H, Grilley B, Rooney CM, Brenner MK, Heslop HE, Dotti G. Clinical responses with T lymphocytes targeting malignancy-associated kappa light chains. J Clin Invest. 2016;126(7):2588-96. doi: 10.1172/JCI86000. PubMed PMID: 27270177; PMCID: PMC4922690.
  5. Rosario AM, Cruz PE, Ceballos-Diaz C, Strickland MR, Siemienski Z, Pardo M, Schob KL, Li A, Aslanidi GV, Srivastava A, Golde TE, Chakrabarty P. Microglia-specific targeting by novel capsid-modified AAV6 vectors. Mol Ther Methods Clin Dev. 2016 Apr 13;3:16026. doi: 10.1038/mtm.2016.26. eCollection 2016. PMID: 27308302, PMCID: PMC4909093
  6. Turtle CJHanafi LABerger CGooley TACherian SHudecek MSommermeyer DMelville KPender BBudiarto TMRobinson ESteevens NNChaney CSoma LChen XYeung CWood BLi DCao JHeimfeld SJensen MCRiddell SRMaloney DG. CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. J Clin Invest. 2016 Jun 1, 126(6):2123-38. doi: 10.1172/JCI85309. Epub 2016 Apr 25. PMC4887159
  7. Turtle, CJ, Hanafi, LA, Berger, C, Gooley,TA, Cherian, S, Hudecek, M, Sommermeyer, D, Melville, K, Pender, B, Budiarto, TM, Robinson, E, Steevens, NN,  Chaney C, Soma, L, Chen X, Yeung, C, Wood, B, Li, D, Cao, J, Heimfeld, S, Jensen, MC., Riddell, SR and  Maloney DG. 2016. CD19 CAR-T cells of defined CD4+: CD8+ composition for adult B-cell ALL. The Journal of Clinical Investigation. 126(6):2123-38. PMID: 27111235 PMCID: PMC4887159
  8. Turtle, CJ, L.A. Hanafi, LA, Berger, C, Hudecek, M, Pender, B, Robinson, E, Hawkins, R, R, Chaney, C, Cherian, S, Chen,X, Soma, L, Wood, B, Li, D, Heimfeld,S,  Riddell, SR, Maloney, DG: Immunotherapy of non-Hodgkin lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells. Sci Trans Med. 8(355), 355ra116. PMID: 27605551 PMCID: PMC5045301

 

2017

  1. Ahmed N,  Brawley V,  Bielamowicz K, Hegde M,  Kalra M, Landi D, Robertson C, Gray TL, Diouf O, Wakefield A, Ghazi A, Gerken C, Yi Z, Ashoori A, Wu M-F, Liu H, Rooney CM, Dotti G, Gee A, Su J,  Kew Y, Baskin D, Zhang YJ, New P, Grilley B, Stojakovic M, Hicks J, Powell SZ, Brenner MK, Heslop HE, Grossman R, Wels WS, Gottschalk S. HER2-specific Chimeric Antigen Receptor–modified virus-specific T-cells for progressive Glioblastoma: a Phase I dose-escalation Trial. JAMA Onc 2017 (in press) Aug 1; 3(8):1094-1101 PMID: 28426845 PMCID: PMC5747970 DOI: 10.1001/jamaoncol.2017.0184
  2. Ali, S.A., Shi, V., Maric, I., Wang, M., Stroncek, D.F., Rose, J.J., Brudno, J.N., Stetler-Stevenson, M., Feldman, S.A., Hansen, B.G., Fellowes, V.S., Hakim, F.T., Gress, R.E. and Kochenderfer, J.N., T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma Blood 128: 1688-1700, 2016. PMID: 27412889, PMC5043125 available 2017.
  3. Brudno, J.N., Somerville, R.P.T., Shi, V., Rose, J.J., Halverson, D.C., Fowler, D.H., Gea-Banacloche, J.C., Pavletic, S.Z., Hickstein, D.D., Lu, T.L., Feldman, S.A., Iwamoto, A.T., Kurlander, R., Maric, I., Goy, A., Hansen, B.G., Wilder, J.S., Blacklock-Schuver, B., Hakim, F.T., Rosenberg, S.A., Gress, R.E. and Kochenderfer, J.N., Allogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell transplantation without causing graft-versus-host disease Journal of Clinical Oncology 34: 1112-1121, 2016. PMID: 26811520, PMCID: PMC4872017
  4. Cooper AR, Lill GR, Shaw K, Carbonaro-Sarracino DA, Davila A, Sokoic R, Candotti F, Pellegrini M, Kohn DB. Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients. Blood 2017 May 11; 129(19):2624-2635 PMID 28351939, PMC5428461
  5. Heczey A, Louis CU, Savoldo B, Dakhova O, Durett A, Grilley B, Liu H, Wu MF, Mei Z, Gee A, Mehta B, Zhang H, Mahmood N, Tashiro H, Heslop HE, Dotti G, Rooney CM, Brenner MK. CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma. Mol Ther. 2017. PMID: 28602436, PMC5589058. Available on 2018-09--6
  6. Ramos CA, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, Liu E, Carrum G, Kamble RT, Gee AP, Mei Z, Wu MF, Liu H, Grilley B, Rooney CM, Brenner MK, Heslop HE, Dotti G. Clinical responses with T lymphocytes targeting malignancy-associated kappa light chains. J Clin Invest. 2016;126(7):2588-96;  PMID: 27270177PMCID: PMC4922690.
  7. Ramos CA, Ballard B, Zhang H, Dakhova O, Gee AP, Mei Z, Bilgi M, Wu MF, Liu H, Grilley B, Bollard CM, Chang BH, Rooney CM, Brenner MK, Heslop HE, Dotti G, Savoldo B. Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes. J Clin Invest. 2017;127(9):3462-71; PMCID: 5669573.
  8. Shaw, A. M., Joseph, G. L., Jasti, A. C., Sastry-Dent, L., Witting, S., Cornetta, K. Differences in vector-genome processing and illegitimate integration of non-integrating lentiviral vectors. Gene Ther. 24, 12–20, 2017. PMC5269419
  9. Shaw KL, Garabedian E, Mishra S, Barman P, Davila A, Carbonaro D, Shupien S, Silvin C, Geiger S, Nowicki B, Smogorzewska EM, Brown B, Wang X, de Oliveira S, Choi Y, Ikeda A, Terrazas D, Fu PY, Yu A, Fernandez BC, Cooper AR, Engel B, Podsakoff G, Balamurugan A, Anderson S, Muul L, Jagadeesh GJ, Kapoor N, Tse J, Moore TB, Purdy K, Rishi R, Mohan K, Skoda-Smith S, Buchbinder D, Abraham RS, Scharenberg A, Yang OO, Cornetta K, Gjertson D, Hershfield M, Sokolic R, Candotti F, Kohn DB. Clinical Efficacy of gene-modified stem cells in adenosine deaminase-deficieint immunodeficiency. J Clin Invest. 2017 May 1;127(5):1689-1699. doi: 10.1172/JCI90367. Epub 2017 Mar 27. PMID: 28346229, PMCID: PMC5409097
  10. Yeku O1, Slovin SF. Immune Therapy for Prostate Cancer. Cancer J. 2016 Sep/Oct;22(5):334-341. PMID: 27749327, PMCID: PMC5117426 Available on 2017-09-01

 

2018

  1. Bollard CM, Tripic T, Cruz CR, Dotti G, Gottschalk S, Torrano V, Dakhova O, Carrum G, Ramos CA, Liu H, Wu MF, Marcogliese AN, Barese C, Zu Y, Lee DY, O'Connor O, Gee AP, Brenner MK, Heslop HE, Rooney CM. Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma. J Clin Oncol. 2018;36(11):1128-39; PMCID: 5891126.
  2. Gaub B.M., Berry M.H., Visel M., Holt A., Isacoff E.Y., Flannery J.G. (2018) Optogenetic Retinal Gene Therapy with the Light Gated GPCR Vertebrate Rhodopsin. In: Boon C., Wijnholds J. (eds) Retinal Gene Therapy. Methods in Molecular Biology, vol 1715. Humana Press, New York, NY, 2018;1715:177-189. doi: 10.1007/978-1-4939-7522-8_12. PMID: 29188513
  3. Heslop HE, Brenner MK. Seek and You Will Not Find: Ending the Hunt for Replication-Competent Retroviruses during Human Gene Therapy. Mol Ther. 2018; 26(1):1-2; PMCID: 5763151.
  4. Heczey A, Louis CU, Savoldo B, Dakhova O, Durett A, Grilley B, Liu H, Wu MF, Mei Z, Gee A, Mehta B, Zhang H, Mahmood N, Tashiro H, Heslop HE, Dotti G, Rooney CM, Brenner MK. CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma. Mol Ther. 2017; 25(9):2214-24; PMCID: 5589058
  5. Lyon D, Lapteva N, Gee AP. Absence of Replication-Competent Retrovirus in Vectors, T Cell Products, and Patient Follow-Up Samples. Mol Ther. 2018;26(1):6-7; PMCID: 5763145.
  6. Ramos CA, Rouce R, Robertson CS, Reyna A, Narala N, Vyas G, Mehta B, Zhang H, Dakhova O, Carrum G, Kamble RT, Gee AP, Mei Z, Wu MF, Liu H, Grilley B, Rooney CM, Heslop HE, Brenner MK, Savoldo B, Dotti G. In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas. Mol Ther.2018;26(12):2727-37. Epub 2018/10/13; PMCID: PMC6277484. 
  7. Cornetta, K., Duffy, L., Turtle, C.J., Jensen, M., Forman, S., Binder-Scholl, G. Fry, T., Chew, A., Maloney, D. G., and June, C.H. Absence of Replication Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products. Molecular Therapy 28:280-288. 2018. PMC5762981
  8. Cornetta, K., Duffy, L.,  Feldman, S.A., , Mackall, C.A., Davila, M.L., Curran, K.J., Junghans,  R.P., Tang, J.Y., James Kochenderfer, J., O’Cearbhaill, R., Archer, G., Kiem, H-P., Shah, N.L., Delbrook, C., Kaplan, R., Brentjens, R. J., Riviére, I., Sadelein, M., and Rosenberg, S.A.  Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience.  Molecular Therapy: Methods & Clinical Development (2018) https://doi/org/10.1016/j.omtm.2018.08.006   PMC6134358

 

2019

  1. Berry MH, Holt A, Salari A, et al. Restoration of high-sensitivity and adapting vision with a cone opsin. Nat Commun. 2019;10(1):1221. Published 2019 Mar 15. doi:10.1038/s41467-019-09124-x, PMD: 30874546: PMCID: PMC6420663
  2. Mamcarz E, Zhou S, Lockey T, Abdelsamed H, Cross SJ, Kang G, Ma Z, Condori J, Dowdy J, Triplett B, Li C, Maron G, Aldave Becerra JC, Church JA, Dokmeci E, Love JT, da Matta Ain AC, van der Watt H, Tang X, Janssen W, Ryu BY, De Ravin SS, Weiss MJ, Youngblood B, Long-Boyle JR, Gottschalk S, Meagher MM, Malech HL, Puck JM, Cowan MJ, Sorrentino BP. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1. N Engl J Med. 2019 Apr 18;380(16):1525-1534. doi: 10.1056/NEJMoa1815408.
  3. Nowicki TS, Berent-Maoz B, Cheung-Lau G, Huang RR, Wang X, Tsoi J, Kaplan-Lefko P, Cabrera P, Tran J, Pang J, Macabali M, Garcilazo IP, Carretero IB, Kalbasi A, Cochran AJ, Grasso CS, Hu-Lieskovan S, Chmielowski B, Comin-Anduix B, Singh A, Ribas A. A Pilot Trial of the Combination of Transgenic NY-ESO-1–reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab. Clin Cancer Res, 2019 Apr 1;25(7):2096-2108: doi:10.1158/1078-0432.CCR-18-3496. Epub. PMID: 30573690, PMICD: PMC56445780 (Available on 2020-04-01).